These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 34839824)

  • 1. Circular RNA circVAPA contributes to non-small-cell lung cancer progression via miR-342-3p-dependent regulation of ZEB2.
    Liu X; Cheng Y; Wang Y; Zhang Y
    World J Surg Oncol; 2021 Nov; 19(1):335. PubMed ID: 34839824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circ-10720 as a ceRNA adsorbs microRNA-1238 and modulates ZEB2 to boost NSCLC development by activating EMT.
    Zhang W; Xiao P; Liu B; Zhang Y
    Eur J Med Res; 2024 Apr; 29(1):226. PubMed ID: 38610009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CircVAPA exerts oncogenic property in non-small cell lung cancer by the miR-876-5p/WNT5A axis.
    Zhao Y; Dai Q; Fu X; Chen Q; Tang Y; Gao X; Zhou Q
    J Gene Med; 2021 Jun; 23(6):e3325. PubMed ID: 33619796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-507 represses the malignant behaviors of non-small cell lung cancer via targeting zinc finger E-box binding homeobox 2.
    Lv HL; Li ZL; Song YB
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9955-9964. PubMed ID: 31799665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CircVAPA promotes small cell lung cancer progression by modulating the miR-377-3p and miR-494-3p/IGF1R/AKT axis.
    Hua J; Wang X; Ma L; Li J; Cao G; Zhang S; Lin W
    Mol Cancer; 2022 Jun; 21(1):123. PubMed ID: 35668527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circ_0007385 promotes the proliferation and inhibits the apoptosis of non-small cell lung cancer cells via miR-337-3p-dependent regulation of LMO3.
    Wei M; Yin R; Qu L; Tang J
    Histol Histopathol; 2023 Jul; 38(7):797-810. PubMed ID: 36426731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells.
    Ye Y; Zhao L; Li Q; Xi C; Li Y; Li Z
    Thorac Cancer; 2020 Aug; 11(8):2196-2208. PubMed ID: 32602212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circ_0074027 contributes to non-small cell lung cancer progression through positively modulating RHOA via sequestering miR-2467-3p.
    Duan Z; Wei S; Liu Y
    J Bioenerg Biomembr; 2021 Apr; 53(2):223-233. PubMed ID: 33687619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circ_0020123 plays an oncogenic role in non-small cell lung cancer depending on the regulation of miR-512-3p/CORO1C.
    Zhang H; Huang T; Yuan S; Long Y; Tan S; Niu G; Zhang P; Yang M
    Thorac Cancer; 2022 May; 13(9):1406-1418. PubMed ID: 35388975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 11. Circ_0001715 Functions as a miR-1249-3p Sponge to Accelerate the Progression of Non-small Cell Lung Cancer via Upregulating the Level of FGF5.
    Zhang Q; Ding F; Zhang C; Han X; Cheng H
    Biochem Genet; 2023 Oct; 61(5):1807-1826. PubMed ID: 36808266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer.
    Wang L; Tong X; Zhou Z; Wang S; Lei Z; Zhang T; Liu Z; Zeng Y; Li C; Zhao J; Su Z; Zhang C; Liu X; Xu G; Zhang HT
    Mol Cancer; 2018 Sep; 17(1):140. PubMed ID: 30261900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular RNA circ_0010235 sponges miR-338-3p to play oncogenic role in proliferation, migration and invasion of non-small-cell lung cancer cells through modulating KIF2A.
    Zhu Y; Ma C; Lv A; Kou C
    Ann Med; 2021 Dec; 53(1):693-706. PubMed ID: 34024242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [miR-367-3p Regulates Cells Proliferation and Invasion in NSCLC by Targeting ZEB2].
    Su Y; Zhang H
    Zhongguo Fei Ai Za Zhi; 2022 Nov; 25(11):782-788. PubMed ID: 36419391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circ_0000463 contributes to the progression and glutamine metabolism of non-small-cell lung cancer by targeting miR-924/SLC1A5 signaling.
    Liu Y; Wang S; Pan S; Yan Q; Li Y; Zhao Y
    J Clin Lab Anal; 2022 Jan; 36(1):e24116. PubMed ID: 34811815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of hsa_circ_0136666 predicts poor prognosis and initiates osteosarcoma tumorigenesis through miR-593-3p/ZEB2 pathway.
    Zhang C; Zhou H; Yuan K; Xie R; Chen C
    Aging (Albany NY); 2020 May; 12(11):10488-10496. PubMed ID: 32424109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hsa_circ_0003528 promotes cell malignant transformation and immune escape via increasing oncogene PDL1 through sponging miR-511-3p in non-small cell lung cancer.
    Wang G; Deng L; Gong K; Zhou P; Peng L; Li C
    Environ Toxicol; 2023 Jun; 38(6):1347-1360. PubMed ID: 36947452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA circCPA4 promotes tumorigenesis by regulating miR-214-3p/TGIF2 in lung cancer.
    Tao W; Cao C; Ren G; Zhou D
    Thorac Cancer; 2021 Dec; 12(24):3356-3369. PubMed ID: 34741437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the miR-6734-3p/ZEB2 axis hampers development of non-small cell lung cancer (NSCLC) and increases susceptibility of cancer cells to cisplatin treatment.
    Wei L; Jiang J
    Bioengineered; 2021 Dec; 12(1):2499-2510. PubMed ID: 34107856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circ_0006220 Contributes to NSCLC Progression through miR-342-3p/GOT2 Axis.
    Tang J; Li X; Zhao L; Hui J; Ding N
    Ann Thorac Cardiovasc Surg; 2023 Feb; 29(1):11-22. PubMed ID: 36575008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.